• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于为轻度痴呆或轻度认知障碍患者及其照顾者提供护理支持的基于技术的干预措施的经济评估:一项系统综述。

Economic evaluations of technology-based interventions used to provide care support for people with mild dementia or mild cognitive impairment and their caregivers: A systematic review.

作者信息

Vargas-Martínez Ana Magdalena

机构信息

Department of Nursing, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, Seville, Spain.

出版信息

J Alzheimers Dis. 2024 Dec;102(3):597-616. doi: 10.1177/13872877241291070. Epub 2024 Nov 8.

DOI:10.1177/13872877241291070
PMID:39512098
Abstract

BACKGROUND

The cost-effectiveness of interventions is a key issue owing to the limited resources of healthcare services.

OBJECTIVE

To conduct a systematic review of economic evaluations of technology-based healthcare interventions in care support for people with dementia or mild cognitive impairment (MCI) and their caregivers, and of the tools used to assess effectiveness and costs.

METHODS

The following databases were used: PubMed, National Health Service Economic Evaluation Database, and Health Technology Assessment. A total of 207 articles from 2012 to 2024 were identified and then screened.

RESULTS

Seventeen studies were included, of which nine were study protocols. Almost half (n = 8) the interventions were multicomponent. The most common components used in the interventions were cognitive stimulation, physical functioning and continuing support. Regarding the efficiency results of these interventions, only three studies provided a full economic evaluation. The most frequent tools in the economic evaluations used to measure effectiveness (measured in quality-adjusted life years) and costs were the European Quality of Life-5 Dimensions and Resource Utilization in Dementia instruments, respectively.

CONCLUSIONS

Most of the interventions evaluated were cost-effective. However, these results should be interpreted with caution, given the scarcity of the literature, and further economic evaluations of technology-based healthcare interventions for people with mild dementia or MCI care support and their caregivers are therefore needed. Additionally, a meta-analysis could not be performed due to the heterogeneity of the data.

摘要

背景

由于医疗服务资源有限,干预措施的成本效益是一个关键问题。

目的

对基于技术的医疗干预措施在痴呆症或轻度认知障碍(MCI)患者及其照护者护理支持方面的经济评估,以及用于评估有效性和成本的工具进行系统评价。

方法

使用了以下数据库:PubMed、英国国家卫生服务体系经济评估数据库和卫生技术评估数据库。共识别并筛选了2012年至2024年的207篇文章。

结果

纳入了17项研究,其中9项为研究方案。几乎一半(n = 8)的干预措施是多组分的。干预措施中最常用的组分是认知刺激、身体功能和持续支持。关于这些干预措施的效率结果,只有三项研究提供了全面的经济评估。经济评估中用于衡量有效性(以质量调整生命年衡量)和成本的最常用工具分别是欧洲五维健康量表和痴呆症资源利用工具。

结论

大多数评估的干预措施具有成本效益。然而,鉴于文献稀缺,这些结果应谨慎解读,因此需要对基于技术的医疗干预措施在轻度痴呆症或MCI患者护理支持及其照护者方面进行进一步的经济评估。此外,由于数据的异质性,无法进行荟萃分析。

相似文献

1
Economic evaluations of technology-based interventions used to provide care support for people with mild dementia or mild cognitive impairment and their caregivers: A systematic review.用于为轻度痴呆或轻度认知障碍患者及其照顾者提供护理支持的基于技术的干预措施的经济评估:一项系统综述。
J Alzheimers Dis. 2024 Dec;102(3):597-616. doi: 10.1177/13872877241291070. Epub 2024 Nov 8.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
5
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
6
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
7
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.多奈哌齐、加兰他敏、利伐斯的明和美金刚治疗阿尔茨海默病的有效性和成本效果(技术评估第 111 号回顾):系统评价和经济模型。
Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210.
8
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.
9
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.仑伐替尼联合帕博利珠单抗治疗未经治疗的晚期肾细胞癌:系统评价和成本效果分析。
Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238.
10
Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.中重度慢性阻塞性肺疾病(COPD)患者的支持性自我管理:证据综合与经济分析
Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360.

引用本文的文献

1
Effectiveness, Adoption Determinants, and Implementation Challenges of ICT-Based Cognitive Support for Older Adults with MCI and Dementia: A PRISMA-Compliant Systematic Review and Meta-Analysis (2015-2025).基于信息通信技术的认知支持对轻度认知障碍和痴呆老年人的有效性、采用决定因素及实施挑战:一项遵循PRISMA标准的系统评价和荟萃分析(2015 - 2025年)
Healthcare (Basel). 2025 Jun 13;13(12):1421. doi: 10.3390/healthcare13121421.